Recruiting OBSERVATIONAL NCT05826444

Microvascular Cardiac Allograft Vasculopathy Trial (mCAV)

Morphological and Functional Phenotype of Isolated Microvascular Cardiac Allograft Vasculopathy in Heart Transplant Recipients

Sponsor: Deutsche Stiftung für Herzforschung

Conditions Cardiac Allograft Vasculopathy

Interventions Angio-IMR Echocardiography Genetics Histology IMR Magnetic resonance imaging Magnetocardiography calcium signaling

Updated 3 times since 2023 Last updated: Aug 8, 2024 Started: Oct 1, 2022 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Allograft Vasculopathy and is currently actively recruiting participants. Deutsche Stiftung für Herzforschung leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deutsche Stiftung für Herzforschung
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
German Heart Institute

Data source: German Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany